Kerry Wentworth's most recent trade in Nuvation Bio Inc - Ordinary Shares - Class A was a trade of 26,000 Class A Common Stock done at an average price of $1.8 . Disclosure was reported to the exchange on June 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvation Bio Inc - Ordinar... | Kerry Wentworth | CHIEF REGULATORY OFFICER | Purchase of securities on an exchange or from another person at price $ 1.79 per share. | 16 Jun 2025 | 26,000 | 26,000 | - | 1.8 | 46,540 | Class A Common Stock |
| Nuvation Bio Inc - Ordinar... | Kerry Wentworth | CHIEF REGULATORY OFFICER | Purchase of securities on an exchange or from another person at price $ 1.80 per share. | 16 Jun 2025 | 24,000 | 50,000 | - | 1.8 | 43,200 | Class A Common Stock |
| Nuvation Bio Inc - Ordinar... | Kerry Wentworth | CHIEF REGULATORY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc - Ordinar... | Kerry Wentworth | CHIEF REGULATORY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc - Ordinar... | Kerry Wentworth | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) |